Please find enclosed herewith the financial results for the half year and year ended as on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 3.1 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Royal Sense Limited submitted audited financial results for FY25 (year ended 31 March 2025), along with a separate utilization certificate for its March 2025 preferential issue. Consolidated revenue from operations jumped to ₹6,173.40 lakhs from ₹1,780.02 lakhs in FY24, a roughly 247% rise, largely powered by its wholly owned subsidiary Stergic Retail Private Limited (₹3,816.73 lakhs in revenue). Consolidated profit after tax climbed to ₹633.12 lakhs from ₹158.88 lakhs, with basic EPS of ₹12.91 versus ₹3.24. The auditor M/s C N D & Associates issued an unmodified (clean) opinion on both standalone and consolidated results, replacing the prior year's auditor. Net cash from operating activities swung to positive ₹113.93 lakhs (consolidated) versus a negative ₹387.19 lakhs in FY24. Standalone reserves turned positive at ₹1,742.91 lakhs from a negative ₹343.57 lakhs, and total equity rose to ₹2,456.38 lakhs.
Strong revenue and earnings growth — much of it from the newly contributing subsidiary — should be viewed positively by shareholders, and the clean audit opinion and return to positive operating cash flow reinforce confidence. Short-term borrowings more than doubled (₹138.28 to ₹315.15 lakhs standalone) and trade receivables/inventories have expanded sharply, signalling working-capital strain worth watching.